Preclinical Toxicity Testing

The National Institutes of Health (NIH) intends to award a Firm-Fixed-Price Purchase Order to Jai Research Foundation for preclinical toxicity testing. The testing is required for six new novel drugs to be used in the National Institute of Health's (NIH) translational medicine field. The tests must be consistent with previous testing completed by Jai Research Foundation. The notice is not a request for competitive quotes, but small businesses may submit a written capability statement to demonstrate their ability to perform the requirement. • The testing must be consistent with all previous testing completed by Jai Research Foundation. • The tests are predictive of safety for new novel drug candidates. • The data is required for publications in drug discovery journals. • The testing must be consistent with established protocols to avoid any recalibration of old data.